Background Patients with heart failure (HF) frequently suffer from undetected declines in cardiorespiratory fitness (CRF), which significantly increases their risk of poor outcomes. However, current ...
Background People living with HIV (PWH) are at increased risk of cardiovascular disease; however, evidence from Asian populations remains limited. We evaluated the prevalence and characteristics of ...
Background Delays in performing urgent coronary artery bypass graft (CABG) surgery are increasing across the UK, with ...
Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Background Invasive coronary function testing (CFT) is indicated in patients with refractory angina with non-obstructed coronary arteries (ANOCA). Despite this, questions remain regarding patient ...
Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...
Introduction Cardiac MRI (CMRI) is an important investigation in cases of unclear cause of sudden cardiac arrest (SCA). It demonstrates diagnostic utility in assessing reversibility and tissue scar ...
Aim In the UK, pharmacological management of patients with heart failure (HF) occurs predominantly in general practice. Using data from the Clinical Practice Research Datalink, we examined the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results